DeutschNewstral
Article
Tthestreet.com on 2023-12-22 13:58
Karuna Therapeutics soars after $14 billion takeover by Bristol Myers
Related news
- DKaruna Therapeutics soars after $14 billion takeover by Bristol Myersdcourier.com
- MBristol Myers Squibb to purchase Karuna Therapeuticsmvtelegraph.com
Bristol Myers Squibb acquires Karuna Therapeutics for $14 billion, boosting neuroscience portfolioSeattle Times- TBristol Myers to buy cancer specialists Mirati Therapeutics for $5.8 billionthestreet.com
- TRayzeBio soars; Bristol Myers to pay $4.1 billion in second major buy in 3 daysthestreet.com
- TBristol-Myers To Buy Turning Point Therapeutics In $4.1 Billion Oncology Dealthestreet.com
Century Therapeutics shares soar on potential multibillion-dollar deal with Bristol Myers Squibbbizjournals.com- Inside the deal: Why Century Therapeutics picked Bristol Myers Squibb for its first Big Pharma mega-dealbizjournals.com
- IBristol-Myers buying Karuna signals a biotech boom ahead: Jefferiesinvezz.com
- TAmbrx Biopharma soars on $2 billion takeover by Johnson & Johnsonthestreet.com
Bristol Myers to Acquire the Drugmaker Karuna for $14 BillionThe New York Times- BBristol Myers CEO Chris Boerner Buys Up Stock1 min readbarrons.com
Signet Jewelers, Bristol-Myers risedailyherald.com
Bristol Myers Squibb buys San Diego cancer therapy company for $4.8Bsandiegouniontribune.com- TBristol Myers Q2 Earnings Top Street Forecasts On Solid Eliquis and Opdivo Salesthestreet.com
- DBristol Myers slumps as Bayer trial failure casts doubt on $5 billion drugdcourier.com